{
    "xml": "<topic id=\"PHP3853\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/valaciclovir\" basename=\"valaciclovir\" title=\"VALACICLOVIR\">\n<title>VALACICLOVIR</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_394\" namespace=\"/interactions/list-of-drug-interactions/antivirals/valaciclovir\">Valaciclovir</xref>\n</p>\n<data name=\"vtmid\">324820003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_298642086\" title=\"Nucleoside analogues\">Nucleoside analogues</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP43604\" outputclass=\"indicationsAndDose\" rev=\"1.25\" parent=\"/drugs/valaciclovir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes zoster infection, treatment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;g 3 times a day for 7 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes zoster infection, treatment in immunocompromised patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;g 3 times a day for at least 7 days and continued for 2 days after crusting of lesions.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex, treatment of first infective episode</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg twice daily for 5 days (longer if new lesions appear during treatment or healing is incomplete).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex infections treatment of first episode in immunocompromised or HIV-positive patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;g twice daily for 10 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex, treatment of recurrent infections</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg twice daily for 3&#8211;5 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of recurrent herpes simplex infections in immunocompromised or HIV-positive patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;g twice daily for 5&#8211;10 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes labialis treatment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 2&#8239;g, then 2&#8239;g after 12&#8239;hours.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 2&#8239;g, then 2&#8239;g after 12&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex, suppression of infections</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg daily in 1&#8211;2 divided doses, therapy to be interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex, suppression of infections in immunocompromised or HIV-positive patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg twice daily, therapy to be interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Genital herpes, reduction of transmission (administered on expert advice)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg daily, to be taken by the infected partner.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of cytomegalovirus disease following solid organ transplantation</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8239;g 4 times a day usually for 90 days, preferably starting within 72 hours of transplantation.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43553\" outputclass=\"unlicensedUse\" rev=\"1.10\" parent=\"/drugs/valaciclovir\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Not licensed for treatment of herpes zoster in children.</p>\n<p>Not licensed for treatment or suppression of herpes simplex infection in immunocompromised or HIV-positive children.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43654\" outputclass=\"cautions\" rev=\"1.13\" parent=\"/drugs/valaciclovir\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Elderly (risk of neurological reactions)</ph> (in adults); <ph outputclass=\"caution\">maintain adequate hydration (especially with high doses)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43597\" outputclass=\"interactions\" rev=\"1.20\" parent=\"/drugs/valaciclovir\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (valaciclovir).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43564\" outputclass=\"sideEffects\" rev=\"1.23\" parent=\"/drugs/valaciclovir\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acute renal failure</ph>; <ph outputclass=\"sideEffect\">anaemia</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">convulsions</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">dysarthria</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">hallucinations</ph>; <ph outputclass=\"sideEffect\">hepatitis</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">neurological reactions</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Neurological reactions</p>\n<p>Neurological reactions (including dizziness, confusion, hallucinations, convulsions, ataxia, dysarthria, and drowsiness) more frequent with higher doses.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43590\" outputclass=\"pregnancy\" parent=\"/drugs/valaciclovir\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Not known to be harmful&#8212;manufacturers advise use only when potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43660\" outputclass=\"breastFeeding\" parent=\"/drugs/valaciclovir\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Significant amount in milk after systemic administration&#8212;not known to be harmful but manufacturer advises caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43616\" outputclass=\"hepaticImpairment\" parent=\"/drugs/valaciclovir\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Manufacturer advises caution with high doses used for herpes labialis and prevention of cytomegalovirus disease&#8212;no information available.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Manufacturer advises caution with high doses used for preventing cytomegalovirus disease&#8212;no information available in children.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43577\" outputclass=\"renalImpairment\" parent=\"/drugs/valaciclovir\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>For <i>herpes zoster</i>, 1&#8239;g every 12 hours if eGFR 30&#8211;50&#8239;mL/ minute/1.73&#8239;m<sup>2</sup> (1&#8239;g every 24 hours if eGFR 10&#8211; 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; 500&#8239;mg every 24 hours if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>).</p>\n<p>For <i>treatment of herpes simplex</i>, 500&#8239;mg (1&#8239;g in immunocompromised or HIV-positive patients) every 24 hours if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n<p>For <i>treatment of herpes labialis</i>, if eGFR 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initially 1&#8239;g, then 1&#8239;g 12 hours after initial dose (if eGFR 10&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initially 500&#8239;mg, then 500&#8239;mg 12 hours after initial dose; if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, 500&#8239;mg as a single dose).</p>\n<p>For <i>suppression of herpes simplex</i>, 250&#8239;mg (500&#8239;mg in immunocompromised or HIV-positive patients) every 24 hours if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n<p>For <i>reduction of genital herpes transmission</i>, 250&#8239;mg every 24 hours if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n<p>Reduce dose according to eGFR for <i>cytomegalovirus prophylaxis</i> following solid organ transplantation (consult product literature).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>For <i>herpes zoster</i>, 1&#8239;g every 12 hours if estimated glomerular filtration rate 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup> (1&#8239;g every 24 hours if estimated glomerular filtration rate 10&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; 500&#8239;mg every 24 hours if estimated glomerular filtration rate less than 10&#8239;mL/ minute/1.73&#8239;m<sup>2</sup>). </p>\n<p>For <i>treatment of herpes simplex</i>, 500&#8239;mg (1&#8239;g in immunocompromised or HIV-positive children) every 24 hours if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>. </p>\n<p>For <i>treatment of herpes labialis</i>, if estimated glomerular filtration rate 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initially 1&#8239;g, then 1&#8239;g 12 hours after initial dose (if estimated glomerular filtration rate 10&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initially 500&#8239;mg, then 500&#8239;mg 12 hours after initial dose; if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, 500&#8239;mg as a single dose). </p>\n<p>For <i>suppression of herpes simplex</i>, 250&#8239;mg (500&#8239;mg in immunocompromised or HIV-positive children) every 24 hours if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n<p>Reduce dose according to estimated glomerular filtration rate for <i>cytomegalovirus prophylaxis</i> following solid organ transplantation (consult product literature).</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Maintain adequate hydration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58678\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.9\" parent=\"/drugs/valaciclovir\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Valaciclovir is a pro-drug of aciclovir.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3853-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/valaciclovir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76757\" title=\"Tablet\" namespace=\"/drugs/valaciclovir/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78257\" namespace=\"/treatment-summaries/herpesvirus-infections\" title=\"Herpesvirus infections\" count=\"4\" rel=\"backlink\">Herpesvirus infections</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78412\" namespace=\"/treatment-summaries/vaginal-and-vulval-conditions\" title=\"Vaginal and vulval conditions\" count=\"1\" rel=\"backlink\">Vaginal and vulval conditions</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78418\" namespace=\"/treatment-summaries/oropharynx-infections-viral\" title=\"Oropharynx infections, viral\" count=\"2\" rel=\"backlink\">Oropharynx infections, viral</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_394\" namespace=\"/interactions/list-of-drug-interactions/antivirals/valaciclovir\" title=\"Valaciclovir\" count=\"1\" rel=\"link\">Valaciclovir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76757\" namespace=\"/drugs/valaciclovir/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP3853",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/valaciclovir",
    "basename": "valaciclovir",
    "title": "VALACICLOVIR",
    "interactants": [
        {
            "id": "bnf_int_394",
            "label": "Valaciclovir"
        }
    ],
    "vtmid": "324820003",
    "drugClassification": [
        "Nucleoside analogues"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Herpes zoster infection, treatment",
                        "html": "Herpes zoster infection, treatment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 g 3 times a day for 7 days.",
                        "html": "<p>1&#8239;g 3 times a day for 7 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes zoster infection, treatment in immunocompromised patients",
                        "html": "Herpes zoster infection, treatment in immunocompromised patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 g 3 times a day for at least 7 days and continued for 2 days after crusting of lesions.",
                        "html": "<p>1&#8239;g 3 times a day for at least 7 days and continued for 2 days after crusting of lesions.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex, treatment of first infective episode",
                        "html": "Herpes simplex, treatment of first infective episode"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg twice daily for 5 days (longer if new lesions appear during treatment or healing is incomplete).",
                        "html": "<p>500&#8239;mg twice daily for 5 days (longer if new lesions appear during treatment or healing is incomplete).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex infections treatment of first episode in immunocompromised or HIV-positive patients",
                        "html": "Herpes simplex infections treatment of first episode in immunocompromised or HIV-positive patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 g twice daily for 10 days.",
                        "html": "<p>1&#8239;g twice daily for 10 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex, treatment of recurrent infections",
                        "html": "Herpes simplex, treatment of recurrent infections"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg twice daily for 3&#8211;5 days.",
                        "html": "<p>500&#8239;mg twice daily for 3&#8211;5 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of recurrent herpes simplex infections in immunocompromised or HIV-positive patients",
                        "html": "Treatment of recurrent herpes simplex infections in immunocompromised or HIV-positive patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 g twice daily for 5&#8211;10 days.",
                        "html": "<p>1&#8239;g twice daily for 5&#8211;10 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes labialis treatment",
                        "html": "Herpes labialis treatment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 2 g, then 2 g after 12 hours.",
                        "html": "<p>Initially 2&#8239;g, then 2&#8239;g after 12&#8239;hours.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 2 g, then 2 g after 12 hours.",
                        "html": "<p>Initially 2&#8239;g, then 2&#8239;g after 12&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex, suppression of infections",
                        "html": "Herpes simplex, suppression of infections"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg daily in 1&#8211;2 divided doses, therapy to be interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.",
                        "html": "<p>500&#8239;mg daily in 1&#8211;2 divided doses, therapy to be interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex, suppression of infections in immunocompromised or HIV-positive patients",
                        "html": "Herpes simplex, suppression of infections in immunocompromised or HIV-positive patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg twice daily, therapy to be interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.",
                        "html": "<p>500&#8239;mg twice daily, therapy to be interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Genital herpes, reduction of transmission (administered on expert advice)",
                        "html": "Genital herpes, reduction of transmission (administered on expert advice)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg daily, to be taken by the infected partner.",
                        "html": "<p>500&#8239;mg daily, to be taken by the infected partner.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of cytomegalovirus disease following solid organ transplantation",
                        "html": "Prevention of cytomegalovirus disease following solid organ transplantation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "2 g 4 times a day usually for 90 days, preferably starting within 72 hours of transplantation.",
                        "html": "<p>2&#8239;g 4 times a day usually for 90 days, preferably starting within 72 hours of transplantation.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Not licensed for treatment of herpes zoster in children.\n\nNot licensed for treatment or suppression of herpes simplex infection in immunocompromised or HIV-positive children.",
                "html": "<p>Not licensed for treatment of herpes zoster in children.</p><p>Not licensed for treatment or suppression of herpes simplex infection in immunocompromised or HIV-positive children.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Elderly (risk of neurological reactions) in adults",
                "html": "Elderly (risk of neurological reactions) in adults",
                "specificity": {
                    "patientType": "adults"
                }
            },
            {
                "type": "cautions",
                "textContent": "maintain adequate hydration (especially with high doses)",
                "html": "maintain adequate hydration (especially with high doses)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (valaciclovir).",
                "html": "<p>Appendix 1 (valaciclovir).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Acute renal failure",
                        "html": "Acute renal failure",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "anaemia",
                        "html": "anaemia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "convulsions",
                        "html": "convulsions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "dysarthria",
                        "html": "dysarthria",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hallucinations",
                        "html": "hallucinations",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hepatitis",
                        "html": "hepatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "neurological reactions",
                        "html": "neurological reactions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fatigue",
                        "html": "fatigue",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Neurological reactions",
                "textContent": "Neurological reactions (including dizziness, confusion, hallucinations, convulsions, ataxia, dysarthria, and drowsiness) more frequent with higher doses.",
                "html": "<p>Neurological reactions (including dizziness, confusion, hallucinations, convulsions, ataxia, dysarthria, and drowsiness) more frequent with higher doses.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Not known to be harmful&#8212;manufacturers advise use only when potential benefit outweighs risk.",
                "html": "<p>Not known to be harmful&#8212;manufacturers advise use only when potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Significant amount in milk after systemic administration&#8212;not known to be harmful but manufacturer advises caution.",
                "html": "<p>Significant amount in milk after systemic administration&#8212;not known to be harmful but manufacturer advises caution.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Manufacturer advises caution with high doses used for herpes labialis and prevention of cytomegalovirus disease&#8212;no information available.",
                "html": "<p>Manufacturer advises caution with high doses used for herpes labialis and prevention of cytomegalovirus disease&#8212;no information available.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Manufacturer advises caution with high doses used for preventing cytomegalovirus disease&#8212;no information available in children.",
                "html": "<p>Manufacturer advises caution with high doses used for preventing cytomegalovirus disease&#8212;no information available in children.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "For herpes zoster, 1 g every 12 hours if eGFR 30&#8211;50 mL/ minute/1.73 m2 (1 g every 24 hours if eGFR 10&#8211; 30 mL/minute/1.73 m2; 500 mg every 24 hours if eGFR less than 10 mL/minute/1.73 m2).\n\nFor treatment of herpes simplex, 500 mg (1 g in immunocompromised or HIV-positive patients) every 24 hours if eGFR less than 30 mL/minute/1.73 m2.\n\nFor treatment of herpes labialis, if eGFR 30&#8211;50 mL/minute/1.73 m2, initially 1 g, then 1 g 12 hours after initial dose (if eGFR 10&#8211;30 mL/minute/1.73 m2, initially 500 mg, then 500 mg 12 hours after initial dose; if eGFR less than 10 mL/minute/1.73 m2, 500 mg as a single dose).\n\nFor suppression of herpes simplex, 250 mg (500 mg in immunocompromised or HIV-positive patients) every 24 hours if eGFR less than 30 mL/minute/1.73 m2.\n\nFor reduction of genital herpes transmission, 250 mg every 24 hours if eGFR less than 15 mL/minute/1.73 m2.\n\nReduce dose according to eGFR for cytomegalovirus prophylaxis following solid organ transplantation (consult product literature).",
                "html": "<p>For <i>herpes zoster</i>, 1&#8239;g every 12 hours if eGFR 30&#8211;50&#8239;mL/ minute/1.73&#8239;m<sup>2</sup> (1&#8239;g every 24 hours if eGFR 10&#8211; 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; 500&#8239;mg every 24 hours if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>).</p><p>For <i>treatment of herpes simplex</i>, 500&#8239;mg (1&#8239;g in immunocompromised or HIV-positive patients) every 24 hours if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p><p>For <i>treatment of herpes labialis</i>, if eGFR 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initially 1&#8239;g, then 1&#8239;g 12 hours after initial dose (if eGFR 10&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initially 500&#8239;mg, then 500&#8239;mg 12 hours after initial dose; if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, 500&#8239;mg as a single dose).</p><p>For <i>suppression of herpes simplex</i>, 250&#8239;mg (500&#8239;mg in immunocompromised or HIV-positive patients) every 24 hours if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p><p>For <i>reduction of genital herpes transmission</i>, 250&#8239;mg every 24 hours if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p><p>Reduce dose according to eGFR for <i>cytomegalovirus prophylaxis</i> following solid organ transplantation (consult product literature).</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "For herpes zoster, 1 g every 12 hours if estimated glomerular filtration rate 30&#8211;50 mL/minute/1.73 m2 (1 g every 24 hours if estimated glomerular filtration rate 10&#8211;30 mL/minute/1.73 m2; 500 mg every 24 hours if estimated glomerular filtration rate less than 10 mL/ minute/1.73 m2).\n\nFor treatment of herpes simplex, 500 mg (1 g in immunocompromised or HIV-positive children) every 24 hours if estimated glomerular filtration rate less than 30 mL/minute/1.73 m2.\n\nFor treatment of herpes labialis, if estimated glomerular filtration rate 30&#8211;50 mL/minute/1.73 m2, initially 1 g, then 1 g 12 hours after initial dose (if estimated glomerular filtration rate 10&#8211;30 mL/minute/1.73 m2, initially 500 mg, then 500 mg 12 hours after initial dose; if estimated glomerular filtration rate less than 10 mL/minute/1.73 m2, 500 mg as a single dose).\n\nFor suppression of herpes simplex, 250 mg (500 mg in immunocompromised or HIV-positive children) every 24 hours if estimated glomerular filtration rate less than 30 mL/minute/1.73 m2.\n\nReduce dose according to estimated glomerular filtration rate for cytomegalovirus prophylaxis following solid organ transplantation (consult product literature).",
                "html": "<p>For <i>herpes zoster</i>, 1&#8239;g every 12 hours if estimated glomerular filtration rate 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup> (1&#8239;g every 24 hours if estimated glomerular filtration rate 10&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; 500&#8239;mg every 24 hours if estimated glomerular filtration rate less than 10&#8239;mL/ minute/1.73&#8239;m<sup>2</sup>). </p><p>For <i>treatment of herpes simplex</i>, 500&#8239;mg (1&#8239;g in immunocompromised or HIV-positive children) every 24 hours if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>. </p><p>For <i>treatment of herpes labialis</i>, if estimated glomerular filtration rate 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initially 1&#8239;g, then 1&#8239;g 12 hours after initial dose (if estimated glomerular filtration rate 10&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initially 500&#8239;mg, then 500&#8239;mg 12 hours after initial dose; if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, 500&#8239;mg as a single dose). </p><p>For <i>suppression of herpes simplex</i>, 250&#8239;mg (500&#8239;mg in immunocompromised or HIV-positive children) every 24 hours if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p><p>Reduce dose according to estimated glomerular filtration rate for <i>cytomegalovirus prophylaxis</i> following solid organ transplantation (consult product literature).</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Maintain adequate hydration.",
                "html": "<p>Maintain adequate hydration.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Valaciclovir is a pro-drug of aciclovir.",
                "html": "<p>Valaciclovir is a pro-drug of aciclovir.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76757",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78257",
                "label": "Herpesvirus infections",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78412",
                "label": "Vaginal and vulval conditions",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78418",
                "label": "Oropharynx infections, viral",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_394",
                "label": "Valaciclovir",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76757",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}